Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$47,000.00

Harnessing Bacterial Effector Proteins for Eukaryotic Synthetic Biology: Unlocking Functional Insights

FY 2024-25

Summary
Numerous bacterial species have evolved to thrive within eukaryotic cells, with bacteria-host relationship ranging from symbiosis to causing diseases. Gram-negative bacteria often use specialized multiprotein complexes, known as secretion systems, to deliver bacterial proteins called "effectors" into host cells. The effectors are evolved to manipulate host cell processes to benefit the bacteria and help it to evade the host's immune response. This remarkable capacity of bacterial effectors to influence specific eukaryotic cell processes holds considerable promise for applications in synthetic biology and biotechnology. Nonetheless, assigning the functions of effectors is challenging due to their limited sequence similarity with characterized protein families, thereby necessitating de novo functional characterization. Legionella pneumophila, an intracellular pathogen, boasts the largest known effector arsenal, with over 360 proteins delivered into host cells via Dot/Icm secretion. Thriving naturally within freshwater amoebae, it can also infect human alveolar macrophages, causing severe pneumonia. This hints at L. pneumophila effectors targeting conserved host functions across diverse eukaryotic cells, sparking intense research interest. However, the functions of many L. pneumophila effectors remain unknown in part due to extensive functional redundancy, rendering direct genetic approaches ineffective. To gain initial insights into L. pneumophila effectors' functions, we employ experimental structural characterization, a method often providing molecular clues that go unnoticed in primary sequence analysis. A recent breakthrough in AI-enabled protein structure modeling enhances this approach, allowing us to complete the analyze of the 3D models of 369 confirmed L. pneumophila effectors. This analysis suggested the presence of 160 potential functional domains in effectors, with more than half previously unnoticed. These cryptic domains include new members of established functional groups, such as cysteine proteases, kinases, a/ß hydrolases, and glycosyltransferases, as well as novel structural arrangements, never previously observed in experimentally defined protein structures hinting at novel functions. Building on this extensive analysis and the substantial experimental arsenal accumulated during the previous phases of this project, we propose an ambitious research program aimed at unraveling the molecular functions of L. pneumophila effectors' cryptic domains and understanding their effects on the host cell. To achieve this goal, we will apply a comprehensive approach, including in vitro assays, structural and biophysical analysis, and yeast and human cell system studies. These combined studies will provide a detailed characterization of cryptic domains within L. pneumophila effectors and their activity inside the host cell, paving the way for novel applications in eukaryotic synthetic biology and biotechnology.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-05806
Name nom
Savchenko, Alexei
Department département
Microbiology, Immunology and Infectious Diseases
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
47000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Harnessing Bacterial Effector Proteins for Eukaryotic Synthetic Biology: Unlocking Functional Insights
Keywords
bacterial secreted effectors; molecular structure; biochemical function; conserved eukaryotic signalling pathways; yeast model system; human cell lines; post translational modifications; protein-protein interactions; x-ray crystallography; single particle cryo-em analysis
Application summary
Numerous bacterial species have evolved to thrive within eukaryotic cells, with bacteria-host relationship ranging from symbiosis to causing diseases. Gram-negative bacteria often use specialized multiprotein complexes, known as secretion systems, to deliver bacterial proteins called "effectors" into host cells. The effectors are evolved to manipulate host cell processes to benefit the bacteria and help it to evade the host's immune response. This remarkable capacity of bacterial effectors to influence specific eukaryotic cell processes holds considerable promise for applications in synthetic biology and biotechnology. Nonetheless, assigning the functions of effectors is challenging due to their limited sequence similarity with characterized protein families, thereby necessitating de novo functional characterization. Legionella pneumophila, an intracellular pathogen, boasts the largest known effector arsenal, with over 360 proteins delivered into host cells via Dot/Icm secretion. Thriving naturally within freshwater amoebae, it can also infect human alveolar macrophages, causing severe pneumonia. This hints at L. pneumophila effectors targeting conserved host functions across diverse eukaryotic cells, sparking intense research interest. However, the functions of many L. pneumophila effectors remain unknown in part due to extensive functional redundancy, rendering direct genetic approaches ineffective. To gain initial insights into L. pneumophila effectors' functions, we employ experimental structural characterization, a method often providing molecular clues that go unnoticed in primary sequence analysis. A recent breakthrough in AI-enabled protein structure modeling enhances this approach, allowing us to complete the analyze of the 3D models of 369 confirmed L. pneumophila effectors. This analysis suggested the presence of 160 potential functional domains in effectors, with more than half previously unnoticed. These cryptic domains include new members of established functional groups, such as cysteine proteases, kinases, a/ß hydrolases, and glycosyltransferases, as well as novel structural arrangements, never previously observed in experimentally defined protein structures hinting at novel functions. Building on this extensive analysis and the substantial experimental arsenal accumulated during the previous phases of this project, we propose an ambitious research program aimed at unraveling the molecular functions of L. pneumophila effectors' cryptic domains and understanding their effects on the host cell. To achieve this goal, we will apply a comprehensive approach, including in vitro assays, structural and biophysical analysis, and yeast and human cell system studies. These combined studies will provide a detailed characterization of cryptic domains within L. pneumophila effectors and their activity inside the host cell, paving the way for novel applications in eukaryotic synthetic biology and biotechnology.